Drawing for ALPHADETECT

USPTO serial 99138586

ALPHADETECT

Reviewed by CopyMark Law Group

Status 730Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
BLUE, MICHALA J
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 730: Status 730 means you filed the first six-month extension to delay filing a Statement of Use after a Notice of Allowance. You must file a Statement of Use or another extension before the new deadline.

Need help with ALPHADETECT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,844*

Plus Government fees of $900

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kelly L. Williams

Kelly L. Williams Quarles & Brady LLP2020 K Street, NW, Suite 400Washington, DC 20006-1806United States

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic kits comprising diagnostic agents, preparations substances and printed instructions in the field of Alpha-1-Antitrypsin Deficiency for medical useACTIVE—
016Printed educational materials and promotional materials in the nature of informational flyers in the field of Alpha-1-Antitrypsin DeficiencyACTIVE—
035Data management services in the nature of analyzing and managing the distribution of medical and scientific research data and information in the field of Alpha-1-Antitrypsin DeficiencyACTIVE—
041Educational services, namely, providing educational courses, seminars, training workshops, in-person educational advisory forums in the field of Alpha-1-Antitrypsin Deficiency and distribution of educational materials in connection therewithACTIVE—
042Medical scientific and research information and research in the field of Alpha-1-Antitrypsin Deficiency; Providing medical and scientific data and research information in the field of Alpha-1-Antitrypsin DeficiencyACTIVE—
044Providing medical information to increase inform research, improve health and worldwide detection and find a cure for of Alpha-1-Antitrypsin Deficiency; Medical laboratory analysis, medical diagnostic, monitoring and reporting services provided by medical laboratories; Consulting services in the field of health provided by telephone call centers and hotlines for patients, families and medical professionals in the field of Alpha-1-Antitrypsin Deficiency; Providing medical information in the field of Alpha-1-Antitrypsin DeficiencyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 21, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 21, 2026EX1GSOU EXTENSION 1 GRANTED—
Jul 21, 2026EXT1SOU EXTENSION 1 FILED—
Jul 21, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 3, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 9, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 9, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 3, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 13, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 13, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Nov 13, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 13, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 13, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 17, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 17, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 17, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 10, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 10, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 10, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 10, 2025DOCKASSIGNED TO EXAMINER—
Jul 11, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 15, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 15, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance